2012
DOI: 10.1016/j.humpath.2012.02.006
|View full text |Cite
|
Sign up to set email alerts
|

Parenchymal-stromal switching for extracellular matrix production on invasion of oral squamous cell carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
17
0
1

Year Published

2012
2012
2017
2017

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 22 publications
(21 citation statements)
references
References 33 publications
3
17
0
1
Order By: Relevance
“…In conclusion, based on the present in vivo and in vitro results and lines of evidence documented in the literature, it is possible to conclude that PAR-2 is required for growth and invasion of oral SCC cells and that it is a novel immunohistochemical marker for histopathologic diagnosis of oral malignancies, in addition to those we have already established [4][5][6][7][8][9][10][11][12][13]28], especially when the differential diagnosis of CIS from epithelial dysplasia is difficult. In the next step, the molecular mechanism for PAR-2 activation in the invading front of oral SCC should be investigated more in detail to open a research field toward an anticancer therapy in which repression of PAR-2 should be targeted.…”
Section: Discussionsupporting
confidence: 60%
See 2 more Smart Citations
“…In conclusion, based on the present in vivo and in vitro results and lines of evidence documented in the literature, it is possible to conclude that PAR-2 is required for growth and invasion of oral SCC cells and that it is a novel immunohistochemical marker for histopathologic diagnosis of oral malignancies, in addition to those we have already established [4][5][6][7][8][9][10][11][12][13]28], especially when the differential diagnosis of CIS from epithelial dysplasia is difficult. In the next step, the molecular mechanism for PAR-2 activation in the invading front of oral SCC should be investigated more in detail to open a research field toward an anticancer therapy in which repression of PAR-2 should be targeted.…”
Section: Discussionsupporting
confidence: 60%
“…ZK-1 cells, a human carcinoma cell system, have been established from a well-differentiated SCC arising in the tongue of a 53-year-old man [12], whereas MK-1 cells, another SCC cell system with highly metastatic potential, have been established from a submandibular lymph node metastatic focus of a tongue SCC from a 57-year-old man [28]. ZK-1 and MK-1 cells were seeded in 25-mL plastic flasks at a cell concentration of 4 × 10 4 in 5 mL Dulbecco's minimal essential medium (DMEM; Gibco, Thermo Fisher Scientific, Waltham, MA) containing 10% fetal calf serum (Gibco), 50 IU/mL penicillin, and 50 μg/mL streptomycin (Gibco) and cultured at 37°C in humidified 5% carbon dioxide 95% air atmosphere.…”
Section: Cellsmentioning
confidence: 99%
See 1 more Smart Citation
“…Cells and Reagents SCC cell systems (lines) (ZK-1, ZK-2, and MK-1) were established from SCC arising in the tongue (ZK-1 and ZK-2) 21 and gingiva (MK-1). 22 Salivary gland adenoid cystic carcinoma (ACC) cell systems (lines), ACC2 and ACC3, were established from ACCs of the palatal minor salivary gland and parotid gland, respectively, 23 and ACCM was subcloned from ACC2 cells as a clone with highly metastatic potential.…”
Section: Materials and Methods Clinical Samplesmentioning
confidence: 99%
“…Histopathologically, OSCC presents as fibrous connective tissue with unusual amounts of extracellular matrix rich in fibroblasts, vascular vessels, and inflammatory cells [26]. Among the local milieu of OSCC stromal spaces, rich in perlecans and inflammatory cells, monocytes or resting macrophages are differentiated into LyC16 high , CD163 + , CD204 + , and CD68 + expressing TAMs.…”
Section: Introductionmentioning
confidence: 99%